UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Epilepsy syndromes in children

Author
Angus Wilfong, MD
Section Editor
Douglas R Nordli, Jr, MD
Deputy Editor
April F Eichler, MD, MPH

INTRODUCTION

The International League Against Epilepsy (ILAE) classification system is used by most epileptologists to categorize seizure types and epilepsy syndromes [1]. This classification system has been revised since its origination in 1981, most recently in 2010 [2,3]. (See "ILAE classification of seizures and epilepsy".)

The ILAE recognizes over twenty electroclinical syndromes, each defined by a distinctive combination of clinical features, signs and symptoms, and electrographic patterns; many of these syndromes begin in childhood (table 1). Epilepsy syndrome classification provides invaluable prognostic, therapeutic, and in the case of familial epilepsies, genetic information [4]. That being said, as an increasing number of genetic mutations have been identified in patients with both inherited and seemingly sporadic electroclinical syndromes, it has become clear that the phenotypic spectrum of various syndromes may be broader than what has been traditionally recognized, and the classification systems will continue to evolve.

This topic will review the clinical features, diagnosis and treatment of some of the more common epilepsy syndromes that begin in infancy and childhood. Neonatal seizures and neonatal epilepsy syndromes are discussed separately. (See "Clinical features, evaluation, and diagnosis of neonatal seizures" and "Etiology and prognosis of neonatal seizures" and "Neonatal epilepsy syndromes" and "Treatment of neonatal seizures".)

Additional topics relevant to the clinical features and diagnosis of seizures and epilepsy in children include the following:

(See "Seizures and epilepsy in children: Classification, etiology, and clinical features".)

                     

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Wed Sep 28 00:00:00 GMT 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1981; 22:489.
  2. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989; 30:389.
  3. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010; 51:676.
  4. Duchowny M, Harvey AS. Pediatric epilepsy syndromes: an update and critical review. Epilepsia 1996; 37 Suppl 1:S26.
  5. Vigevano F. Benign familial infantile seizures. Brain Dev 2005; 27:172.
  6. Cloarec R, Bruneau N, Rudolf G, et al. PRRT2 links infantile convulsions and paroxysmal dyskinesia with migraine. Neurology 2012; 79:2097.
  7. de Vries B, Callenbach PM, Kamphorst JT, et al. PRRT2 mutation causes benign familial infantile convulsions. Neurology 2012; 79:2154.
  8. Marini C, Conti V, Mei D, et al. PRRT2 mutations in familial infantile seizures, paroxysmal dyskinesia, and hemiplegic migraine. Neurology 2012; 79:2109.
  9. Rochette J, Roll P, Szepetowski P. Genetics of infantile seizures with paroxysmal dyskinesia: the infantile convulsions and choreoathetosis (ICCA) and ICCA-related syndromes. J Med Genet 2008; 45:773.
  10. Szepetowski P, Rochette J, Berquin P, et al. Familial infantile convulsions and paroxysmal choreoathetosis: a new neurological syndrome linked to the pericentromeric region of human chromosome 16. Am J Hum Genet 1997; 61:889.
  11. Striano P, Lispi ML, Gennaro E, et al. Linkage analysis and disease models in benign familial infantile seizures: a study of 16 families. Epilepsia 2006; 47:1029.
  12. Weber YG, Jacob M, Weber G, Lerche H. A BFIS-like syndrome with late onset and febrile seizures: suggestive linkage to chromosome 16p11.2-16q12.1. Epilepsia 2008; 49:1959.
  13. Gardiner AR, Bhatia KP, Stamelou M, et al. PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine. Neurology 2012; 79:2115.
  14. Riant F, Roze E, Barbance C, et al. PRRT2 mutations cause hemiplegic migraine. Neurology 2012; 79:2122.
  15. Caraballo R, Pavek S, Lemainque A, et al. Linkage of benign familial infantile convulsions to chromosome 16p12-q12 suggests allelism to the infantile convulsions and choreoathetosis syndrome. Am J Hum Genet 2001; 68:788.
  16. Ebrahimi-Fakhari D, Saffari A, Westenberger A, Klein C. The evolving spectrum of PRRT2-associated paroxysmal diseases. Brain 2015; 138:3476.
  17. Guipponi M, Rivier F, Vigevano F, et al. Linkage mapping of benign familial infantile convulsions (BFIC) to chromosome 19q. Hum Mol Genet 1997; 6:473.
  18. Herlenius E, Heron SE, Grinton BE, et al. SCN2A mutations and benign familial neonatal-infantile seizures: the phenotypic spectrum. Epilepsia 2007; 48:1138.
  19. Striano P, Bordo L, Lispi ML, et al. A novel SCN2A mutation in family with benign familial infantile seizures. Epilepsia 2006; 47:218.
  20. Misra SN, Kahlig KM, George AL Jr. Impaired NaV1.2 function and reduced cell surface expression in benign familial neonatal-infantile seizures. Epilepsia 2008; 49:1535.
  21. Zara F, Specchio N, Striano P, et al. Genetic testing in benign familial epilepsies of the first year of life: clinical and diagnostic significance. Epilepsia 2013; 54:425.
  22. Gardella E, Becker F, Møller RS, et al. Benign infantile seizures and paroxysmal dyskinesia caused by an SCN8A mutation. Ann Neurol 2016; 79:428.
  23. Chahine LM, Mikati MA. Benign pediatric localization-related epilepsies. Part I. Syndromes in infancy. Epileptic Disord 2006; 8:169.
  24. Capovilla G, Vigevano F. Benign idiopathic partial epilepsies in infancy. J Child Neurol 2001; 16:874.
  25. Scheffer IE, Berkovic SF. Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain 1997; 120 ( Pt 3):479.
  26. Myoclonus and epilepsy in childhood. Commission on Pediatric Epilepsy of the International League Against Epilepsy. Epilepsia 1997; 38:1251.
  27. Lombroso CT. Early myoclonic encephalopathy, early infantile epileptic encephalopathy, and benign and severe infantile myoclonic epilepsies: a critical review and personal contributions. J Clin Neurophysiol 1990; 7:380.
  28. Wheless JW, Constantinou JE. Lennox-Gastaut syndrome. Pediatr Neurol 1997; 17:203.
  29. Arzimanoglou A, French J, Blume WT, et al. Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol 2009; 8:82.
  30. Epi4K Consortium, Epilepsy Phenome/Genome Project, Allen AS, et al. De novo mutations in epileptic encephalopathies. Nature 2013; 501:217.
  31. Autry AR, Trevathan E, Van Naarden Braun K, Yeargin-Allsopp M. Increased risk of death among children with Lennox-Gastaut syndrome and infantile spasms. J Child Neurol 2010; 25:441.
  32. Widdess-Walsh P, Dlugos D, Fahlstrom R, et al. Lennox-Gastaut syndrome of unknown cause: phenotypic characteristics of patients in the Epilepsy Phenome/Genome Project. Epilepsia 2013; 54:1898.
  33. Hancock E, Cross H. Treatment of Lennox-Gastaut syndrome. Cochrane Database Syst Rev 2003; :CD003277.
  34. Hancock EC, Cross HH. Treatment of Lennox-Gastaut syndrome. Cochrane Database Syst Rev 2009; :CD003277.
  35. Hancock EC, Cross JH. Treatment of Lennox-Gastaut syndrome. Cochrane Database Syst Rev 2013; :CD003277.
  36. Ng YT, Conry JA, Drummond R, et al. Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome. Neurology 2011; 77:1473.
  37. Conry JA, Ng YT, Paolicchi JM, et al. Clobazam in the treatment of Lennox-Gastaut syndrome. Epilepsia 2009; 50:1158.
  38. Freeman JM. The ketogenic diet: additional information from a crossover study. J Child Neurol 2009; 24:509.
  39. Kostov K, Kostov H, Taubøll E. Long-term vagus nerve stimulation in the treatment of Lennox-Gastaut syndrome. Epilepsy Behav 2009; 16:321.
  40. Shahwan A, Bailey C, Maxiner W, Harvey AS. Vagus nerve stimulation for refractory epilepsy in children: More to VNS than seizure frequency reduction. Epilepsia 2009; 50:1220.
  41. Cukiert A, Burattini JA, Mariani PP, et al. Extended, one-stage callosal section for treatment of refractory secondarily generalized epilepsy in patients with Lennox-Gastaut and Lennox-like syndromes. Epilepsia 2006; 47:371.
  42. Pati S, Deep A, Troester MM, et al. Lennox-Gastaut syndrome symptomatic to hypothalamic hamartoma: evolution and long-term outcome following surgery. Pediatr Neurol 2013; 49:25.
  43. Fernández IS, Chapman KE, Peters JM, et al. The tower of Babel: survey on concepts and terminology in electrical status epilepticus in sleep and continuous spikes and waves during sleep in North America. Epilepsia 2013; 54:741.
  44. Lesca G, Rudolf G, Bruneau N, et al. GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction. Nat Genet 2013; 45:1061.
  45. Lemke JR, Lal D, Reinthaler EM, et al. Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Nat Genet 2013; 45:1067.
  46. Carvill GL, Regan BM, Yendle SC, et al. GRIN2A mutations cause epilepsy-aphasia spectrum disorders. Nat Genet 2013; 45:1073.
  47. Turner SJ, Mayes AK, Verhoeven A, et al. GRIN2A: an aptly named gene for speech dysfunction. Neurology 2015; 84:586.
  48. Caraballo RH, Veggiotti P, Kaltenmeier MC, et al. Encephalopathy with status epilepticus during sleep or continuous spikes and waves during slow sleep syndrome: a multicenter, long-term follow-up study of 117 patients. Epilepsy Res 2013; 105:164.
  49. Van Hirtum-Das M, Licht EA, Koh S, et al. Children with ESES: variability in the syndrome. Epilepsy Res 2006; 70 Suppl 1:S248.
  50. Buzatu M, Bulteau C, Altuzarra C, et al. Corticosteroids as treatment of epileptic syndromes with continuous spike-waves during slow-wave sleep. Epilepsia 2009; 50 Suppl 7:68.
  51. Bartolini E, Falchi M, Zellini F, et al. The syndrome of polymicrogyria, thalamic hypoplasia, and epilepsy with CSWS. Neurology 2016; 86:1250.
  52. Maquet P, Hirsch E, Dive D, et al. Cerebral glucose utilization during sleep in Landau-Kleffner syndrome: a PET study. Epilepsia 1990; 31:778.
  53. Takeoka M, Riviello JJ Jr, Duffy FH, et al. Bilateral volume reduction of the superior temporal areas in Landau-Kleffner syndrome. Neurology 2004; 63:1289.
  54. Bourgeois BF, Landau WM. Landau-Kleffner syndrome and temporal cortical volume reduction: cause or effect? Neurology 2004; 63:1152.
  55. Mikati MA, Shamseddine AN. Management of Landau-Kleffner syndrome. Paediatr Drugs 2005; 7:377.
  56. Aeby A, Poznanski N, Verheulpen D, et al. Levetiracetam efficacy in epileptic syndromes with continuous spikes and waves during slow sleep: experience in 12 cases. Epilepsia 2005; 46:1937.
  57. Kramer U, Nevo Y, Neufeld MY, et al. Epidemiology of epilepsy in childhood: a cohort of 440 consecutive patients. Pediatr Neurol 1998; 18:46.
  58. Sánchez Fernández I, Chapman KE, Peters JM, et al. Continuous Spikes and Waves during Sleep: Electroclinical Presentation and Suggestions for Management. Epilepsy Res Treat 2013; 2013:583531.
  59. Chen XQ, Zhang WN, Yang ZX, et al. Efficacy of levetiracetam in electrical status epilepticus during sleep of children: a multicenter experience. Pediatr Neurol 2014; 50:243.
  60. van den Munckhof B, van Dee V, Sagi L, et al. Treatment of electrical status epilepticus in sleep: A pooled analysis of 575 cases. Epilepsia 2015; 56:1738.
  61. Sánchez Fernández I, Peters JM, An S, et al. Long-term response to high-dose diazepam treatment in continuous spikes and waves during sleep. Pediatr Neurol 2013; 49:163.
  62. Morrell F, Whisler WW, Smith MC, et al. Landau-Kleffner syndrome. Treatment with subpial intracortical transection. Brain 1995; 118 ( Pt 6):1529.
  63. Peltola ME, Liukkonen E, Granström ML, et al. The effect of surgery in encephalopathy with electrical status epilepticus during sleep. Epilepsia 2011; 52:602.
  64. Duran MH, Guimarães CA, Medeiros LL, Guerreiro MM. Landau-Kleffner syndrome: long-term follow-up. Brain Dev 2009; 31:58.
  65. Rapin I, Katzman R. Neurobiology of autism. Ann Neurol 1998; 43:7.
  66. Caplan R, Siddarth P, Stahl L, et al. Childhood absence epilepsy: behavioral, cognitive, and linguistic comorbidities. Epilepsia 2008; 49:1838.
  67. Vega C, Vestal M, DeSalvo M, et al. Differentiation of attention-related problems in childhood absence epilepsy. Epilepsy Behav 2010; 19:82.
  68. Conant LL, Wilfong A, Inglese C, Schwarte A. Dysfunction of executive and related processes in childhood absence epilepsy. Epilepsy Behav 2010; 18:414.
  69. Tassinari, CA, Bureau, M, Thomas, P. Epilepsy with myoclonic absences. In: Epileptic syndromes in infancy, childhood and adolescence, 2nd ed, Roger, J, Bureau, M, Dravet, CH, et al (Eds), John Libbey and Co Ltd 1992. p.151.